Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3815.39 (Glytoucan)

Id:a2faf7ea-e323-5127-b087-42c327d7d4bf

Glytoucan:G53321FS

Results found

Linked to

	Label	Description
	3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G66847YI-GLYCOSEQ00035387 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G40980VP-GLYCOSEQ00022455 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 has canonical residue n-glycan b-d-galp 37 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000059 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G34585DT-GLYCOSEQ00103671 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58990YP-GLYCOSEQ00014432 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G66847YI-GLYCOSEQ00035388 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G66847YI-GLYCOSEQ00035387 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G40980VP-GLYCOSEQ00022455 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has canonical residue n-glycan b-d-galp 37

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000059 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G34585DT-GLYCOSEQ00103671 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58990YP-GLYCOSEQ00014432 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3815.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G66847YI-GLYCOSEQ00035388 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.